Xcout IntelPHYSIOMICS PLC competitors & alternatives
The 12 closest competitors and alternatives to PHYSIOMICS PLC among biotech companies — ranked by similarity to what PHYSIOMICS PLC actually does, not by market-cap band.
Subscribe to see PHYSIOMICS PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About PHYSIOMICS PLC
Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert consulting services to pharmaceutical enterprises across the United Kingdom, the United States, and the European Union. The company's core specialization lies in outsourced quantitative pharmacology and computational biology. They deliver comprehensive modeling, simulation, and data analysis services primarily focused on oncology research and development, utilizing their proprietary Virtual Tumour predictive software. Additionally, Physiomics is engaged in developing innovative technologies for applications within the field of personalized medicine.
PHYSIOMICS PLC at a glance
PHYSIOMICS PLC is a biotech company headquartered in Oxford, United Kingdom, founded in 2001. It is publicly listed (PYC) with a market capitalisation of $2M.
Top 12 PHYSIOMICS PLC competitors
Ranked by semantic similarity — how close each company is to PHYSIOMICS PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Biotechnology
Plato BioPharma, Inc. is a life sciences company headquartered in Westminster, Colorado, that offers expert preclinical drug discovery and pharmacological research services.
Similar biotech company
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
Biotechnology
WuXi Biology provides a comprehensive spectrum of preclinical biology services and solutions for drug discovery, supporting clients from target discovery and validation to hit finding, lead optimization, and candidate selection. The company offers specialized platforms and expertise across major disease areas and therapeutic modalities, including small molecules, oligonucleotides, peptides, and antibodies.
Biotechnology
Propria provides contract research services for pharmaceutical and scientific organizations, specializing in in vitro cardiac contractility testing using proprietary human engineered heart tissues. The company evaluates disease models, new compounds, and gene therapies through contractile profiling and functional cardiac reserve assessments to help predict human pharmacology and de-risk drug discovery.
Biotechnology
Crown Bioscience is a global contract research organization (CRO) headquartered in California that specializes in translational oncology and immuno-oncology drug discovery and development. The company provides comprehensive discovery, preclinical, and translational research platforms.
Similar biotech company
Selvita is an integrated contract research organization that provides comprehensive drug discovery and development services to the pharmaceutical and biotechnology industries. The company supports projects from target validation through preclinical candidate nomination and clinical trial batch manufacturing, specializing in small molecules, biologics, and agroscience under GMP and GLP standards.
Similar biotech company
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
Biotechnology
BioCorteX provides in-silico bridge trials for drug development to map how the microbiome affects a drug's efficacy across different populations. The company serves pharmaceutical science, regulatory, and commercial teams by determining for whom an asset works and why.
Biotechnology
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Similar biotech company
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
Similar biotech company
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of PHYSIOMICS PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for PHYSIOMICS PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →